Literature DB >> 19931706

Rotavirus strain surveillance--an Australian perspective of strains causing disease in hospitalised children from 1997 to 2007.

Carl D Kirkwood1, Karen Boniface, Nada Bogdanovic-Sakran, Paul Masendycz, Graeme L Barnes, Ruth F Bishop.   

Abstract

This study documents rotavirus strains causing severe disease in Australian children during the pre-vaccine era. During the period 1997-2007, rotavirus strains from national multi-centre hospital-based surveillance in Australia were analysed for G and P types. G1P[8] was the dominant genotype identified during the 11-year study, with intermittent peaks associated with genotypes G2P[4], G3P[8] and G9P[8]. The results provide baseline information of the G and P genotypes causing disease in Australian children, and highlight the unpredictable changes in genotype incidence that can occur on both a local and national level. To be optimally effective, rotavirus vaccines must prevent disease caused by all common rotavirus genotypes.

Entities:  

Mesh:

Year:  2009        PMID: 19931706     DOI: 10.1016/j.vaccine.2009.08.070

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  10 in total

1.  Modeling rotavirus strain dynamics in developed countries to understand the potential impact of vaccination on genotype distributions.

Authors:  Virginia E Pitzer; Manish M Patel; Ben A Lopman; Cécile Viboud; Umesh D Parashar; Bryan T Grenfell
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-14       Impact factor: 11.205

2.  Predominance of rotavirus G1[P8] genotype among under-five children with gastroenteritis in Mwanza, Tanzania.

Authors:  Adolfine Hokororo; Benson R Kidenya; Jeremiah Seni; Seheri Mapaseka; Jeffrey Mphahlele; Stephen E Mshana
Journal:  J Trop Pediatr       Date:  2014-05-24       Impact factor: 1.165

Review 3.  Rotavirus infections and vaccines: burden of illness and potential impact of vaccination.

Authors:  Keith Grimwood; Stephen B Lambert; Richard J Milne
Journal:  Paediatr Drugs       Date:  2010-08-01       Impact factor: 3.022

4.  Effect of monovalent rotavirus vaccine on rotavirus disease burden and circulating rotavirus strains among children in Morocco.

Authors:  Mohammed Benhafid; Nezha Elomari; Meryem Azzouzi Idrissi; Ahmed Rguig; Jon R Gentsch; Umesh Parashar; Rajae Elaouad
Journal:  J Med Virol       Date:  2015-03-05       Impact factor: 2.327

5.  Temporal association of rotavirus vaccination and genotype circulation in South Africa: Observations from 2002 to 2014.

Authors:  N A Page; L M Seheri; M J Groome; J Moyes; S Walaza; J Mphahlele; K Kahn; C N Kapongo; H J Zar; S Tempia; C Cohen; S A Madhi
Journal:  Vaccine       Date:  2017-10-27       Impact factor: 3.641

6.  Rotavirus G and P types circulating in the eastern region of Kenya: predominance of G9 and emergence of G12 genotypes.

Authors:  Nicholas M Kiulia; Martin M Nyaga; Mapaseka L Seheri; Marianne Wolfaardt; Walda B van Zyl; Mathew D Esona; Grace Irimu; Murithi Inoti; Bernard W Gatinu; Peter K Njenga; Maureen B Taylor; Atunga Nyachieo
Journal:  Pediatr Infect Dis J       Date:  2014-01       Impact factor: 2.129

7.  Genetic analysis of G12P[8] rotaviruses detected in the largest U.S. G12 genotype outbreak on record.

Authors:  Slavica Mijatovic-Rustempasic; Elizabeth N Teel; Tara K Kerin; Jennifer J Hull; Sunando Roy; Geoffrey A Weinberg; Daniel C Payne; Umesh D Parashar; Jon R Gentsch; Michael D Bowen
Journal:  Infect Genet Evol       Date:  2013-11-21       Impact factor: 3.342

8.  Human rotavirus vaccine Rotarix™ provides protection against diverse circulating rotavirus strains in African infants: a randomized controlled trial.

Authors:  Andrew Duncan Steele; Kathleen M Neuzil; Nigel A Cunliffe; Shabir A Madhi; Pieter Bos; Bagrey Ngwira; Desiree Witte; Stacy Todd; Cheryl Louw; Mari Kirsten; Sanet Aspinall; Leen Jan Van Doorn; Alain Bouckenooghe; Pemmaraju V Suryakiran; Htay Htay Han
Journal:  BMC Infect Dis       Date:  2012-09-13       Impact factor: 3.090

9.  Influence of birth rates and transmission rates on the global seasonality of rotavirus incidence.

Authors:  Virginia E Pitzer; Cécile Viboud; Ben A Lopman; Manish M Patel; Umesh D Parashar; Bryan T Grenfell
Journal:  J R Soc Interface       Date:  2011-04-20       Impact factor: 4.118

10.  Rotavirus vaccine efficacy up to 2 years of age and against diverse circulating rotavirus strains in Niger: Extended follow-up of a randomized controlled trial.

Authors:  Sheila Isanaka; Céline Langendorf; Monica Malone McNeal; Nicole Meyer; Brian Plikaytis; Souna Garba; Nathan Sayinzoga-Makombe; Issaka Soumana; Ousmane Guindo; Rockyiath Makarimi; Marie Francoise Scherrer; Eric Adehossi; Iza Ciglenecki; Rebecca F Grais
Journal:  PLoS Med       Date:  2021-07-02       Impact factor: 11.069

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.